目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Anti-Inflammatory Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 RA - Market size and forecast 2023-2028
Chart on RA - Market size and forecast 2023-2028 ($ billion)
Data Table on RA - Market size and forecast 2023-2028 ($ billion)
Chart on RA - Year-over-year growth 2023-2028 (%)
Data Table on RA - Year-over-year growth 2023-2028 (%)
6.4 Psoriasis - Market size and forecast 2023-2028
Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
6.5 MS - Market size and forecast 2023-2028
Chart on MS - Market size and forecast 2023-2028 ($ billion)
Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Chart on MS - Year-over-year growth 2023-2028 (%)
Data Table on MS - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Drug Class
7.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
7.3 Anti-inflammatory biologicals - Market size and forecast 2023-2028
Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
7.4 Corticosteroids - Market size and forecast 2023-2028
Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
7.5 NSAIDs - Market size and forecast 2023-2028
Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ billion)
Data Table on Market opportunity by Drug Class ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ billion)
Data Tables on Market opportunity By Geographical Landscape($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Alvogen Iceland ehf
Alvogen Iceland ehf - Overview
Alvogen Iceland ehf - Product / Service
Alvogen Iceland ehf - Key offerings
12.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key offerings
12.6 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. - Overview
F. Hoffmann-La Roche Ltd. - Product / Service
F. Hoffmann-La Roche Ltd. - Key offerings
12.11 Ferring BV
Ferring BV - Overview
Ferring BV - Product / Service
Ferring BV - Key offerings
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on RA - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on RA - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on RA - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on RA - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on MS - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on MS - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Application ($ billion)
Exhibits49: Data Table on Market opportunity by Application ($ billion)
Exhibits50: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits51: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Drug Class
Exhibits53: Data Table on Comparison by Drug Class
Exhibits54: Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Exhibits56: Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Drug Class ($ billion)
Exhibits67: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape($ billion)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape($ billion)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Alvogen Iceland ehf - Overview
Exhibits122: Alvogen Iceland ehf - Product / Service
Exhibits123: Alvogen Iceland ehf - Key offerings
Exhibits124: Amgen Inc. - Overview
Exhibits125: Amgen Inc. - Product / Service
Exhibits126: Amgen Inc. - Key offerings
Exhibits127: Amneal Pharmaceuticals Inc. - Overview
Exhibits128: Amneal Pharmaceuticals Inc. - Business segments
Exhibits129: Amneal Pharmaceuticals Inc. - Key news
Exhibits130: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits131: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits132: Bayer AG - Overview
Exhibits133: Bayer AG - Business segments
Exhibits134: Bayer AG - Key news
Exhibits135: Bayer AG - Key offerings
Exhibits136: Bayer AG - Segment focus
Exhibits137: Bristol Myers Squibb Co. - Overview
Exhibits138: Bristol Myers Squibb Co. - Product / Service
Exhibits139: Bristol Myers Squibb Co. - Key news
Exhibits140: Bristol Myers Squibb Co. - Key offerings
Exhibits141: Eli Lilly and Co. - Overview
Exhibits142: Eli Lilly and Co. - Product / Service
Exhibits143: Eli Lilly and Co. - Key news
Exhibits144: Eli Lilly and Co. - Key offerings
Exhibits145: F. Hoffmann-La Roche Ltd. - Overview
Exhibits146: F. Hoffmann-La Roche Ltd. - Product / Service
Exhibits147: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibits148: Ferring BV - Overview
Exhibits149: Ferring BV - Product / Service
Exhibits150: Ferring BV - Key offerings
Exhibits151: GlaxoSmithKline Plc - Overview
Exhibits152: GlaxoSmithKline Plc - Business segments
Exhibits153: GlaxoSmithKline Plc - Key news
Exhibits154: GlaxoSmithKline Plc - Key offerings
Exhibits155: GlaxoSmithKline Plc - Segment focus
Exhibits156: Johnson and Johnson Services Inc. - Overview
Exhibits157: Johnson and Johnson Services Inc. - Business segments
Exhibits158: Johnson and Johnson Services Inc. - Key news
Exhibits159: Johnson and Johnson Services Inc. - Key offerings
Exhibits160: Johnson and Johnson Services Inc. - Segment focus
Exhibits161: Novartis AG - Overview
Exhibits162: Novartis AG - Business segments
Exhibits163: Novartis AG - Key news
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits171: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits172: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits173: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits174: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits175: Viatris Inc. - Overview
Exhibits176: Viatris Inc. - Business segments
Exhibits177: Viatris Inc. - Key news
Exhibits178: Viatris Inc. - Key offerings
Exhibits179: Viatris Inc. - Segment focus
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Information sources
Exhibits185: Data validation
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Data synthesis
Exhibits188: 360 degree market analysis
Exhibits189: List of abbreviations